← back to database
CTI Life Sciences Fund funds early-stage life science companies to accelerate biotech innovation. It focuses on pre-clinical and clinical development stages across Canada, the U.S., and Europe. The firm operates as a knowledge-driven boutique venture capital investor. Its 'Inception-2-Inflection' strategy backs companies from birth to advanced clinical milestones. A seasoned management team supports governance, scientific expertise, and strategic growth.
Investment focus
Investment style
Specialist
Data last enriched
Aug 14, 2026
Investing team
- Ken PastorManaging Partner
- Laurence RulleauManaging Partner
- Youssef BennaniManaging Partner
- Shermaine TileyManaging Partner
- Dana MatzenPartner
- Xin HangSenior Principal